{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:07:29Z","timestamp":1794460049216,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1186\/s12014-025-09546-4","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:11:29Z","timestamp":1759914689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessing the consistency of mass spectrometry, a clinical-laboratory model, and immunohistochemistry in amyloid subtyping: a Brazilian experience"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5254-3486","authenticated-orcid":false,"given":"Roberta Shcolnik","family":"Szor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussara Bianchi","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Andrade","family":"Schuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdemir Melechco","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"9546_CR1","doi-asserted-by":"crossref","unstructured":"Gertz MA, Dispenzieri A. Systemic amyloidosis recognition, prognosis, and therapy: A systematic review. Vol. 324, JAMA - Journal of the American medical association. American Medical Association; 2020. pp. 79\u201389.","DOI":"10.1001\/jama.2020.5493"},{"key":"9546_CR2","doi-asserted-by":"crossref","unstructured":"Muchtar E, Dispenzieri A, Magen H, Grogan M, Mauermann M, McPhail ED, et al. Systemic amyloidosis from A (AA) to T (ATTR): a review. Journal of Internal Medicine. Volume 289. Blackwell Publishing Ltd; 2021. pp. 268\u201392.","DOI":"10.1111\/joim.13169"},{"key":"9546_CR3","doi-asserted-by":"publisher","unstructured":"Buxbaum JN, Eisenberg DS, F\u00e4ndrich M, McPhail ED, Merlini G, Saraiva MJM et al. Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid [Internet]. 2024;31(4):249\u201356. Available from: https:\/\/www.tandfonline.com\/doi\/full\/https:\/\/doi.org\/10.1080\/13506129.2024.2405948","DOI":"10.1080\/13506129.2024.2405948"},{"issue":"10","key":"9546_CR4","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s12325-015-0250-0","volume":"32","author":"I Lousada","year":"2015","unstructured":"Lousada I, Comenzo RL, Landau H, Guthrie S, Merlini G. Light chain amyloidosis: patient experience survey from the amyloidosis research consortium. Adv Ther. 2015;32(10):920\u20138.","journal-title":"Adv Ther"},{"key":"9546_CR5","doi-asserted-by":"publisher","unstructured":"Szor RS, Fernandes F, Lino AMM, Mendon\u00e7a LO, Seguro FS, Feitosa VA et al. Systemic amyloidosis journey from diagnosis to outcomes: a twelve-year real-world experience of a single center in a middle-income country. Orphanet J Rare Dis. 2022;17(1):425. https:\/\/doi.org\/10.1186\/s13023-022-02584-3","DOI":"10.1186\/s13023-022-02584-3"},{"key":"9546_CR6","doi-asserted-by":"crossref","unstructured":"Wisniowski B, Wechalekar A, Karger S. AG; 2020. pp. 312\u201321.","DOI":"10.1159\/000508022"},{"issue":"1","key":"9546_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/13506129.2021.1994386","volume":"29","author":"MD Benson","year":"2022","unstructured":"Benson MD, Berk JL, Dispenzieri A, Damy T, Gillmore JD, Hazenberg BP, et al. Tissue biopsy for the diagnosis of amyloidosis: experience from some centres. Amyloid. 2022;29(1):8\u201313.","journal-title":"Amyloid"},{"issue":"4","key":"9546_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000506696","volume":"143","author":"MM Picken","year":"2020","unstructured":"Picken MM. The pathology of amyloidosis in classification: A review. Acta Haematol. 2020;143(4):322\u201334.","journal-title":"Acta Haematol"},{"issue":"16","key":"9546_CR9","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1182\/blood-2012-03-413682","volume":"120","author":"N Leung","year":"2012","unstructured":"Leung N, Nasr SH, Sethi S. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. Blood. 2012;120(16):3206\u201313.","journal-title":"Blood"},{"issue":"24","key":"9546_CR10","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","volume":"114","author":"JA Vrana","year":"2009","unstructured":"Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114(24):4957\u20139.","journal-title":"Blood"},{"key":"9546_CR11","doi-asserted-by":"publisher","unstructured":"Loo D, Mollee PN, Renaut P, Hill MM. Proteomics in molecular diagnosis: typing of amyloidosis. Biomed Res Int. 2011;2011:754109. https:\/\/doi.org\/10.1155\/2011\/754109","DOI":"10.1155\/2011\/754109"},{"key":"9546_CR12","doi-asserted-by":"crossref","unstructured":"Lavatelli F, Vrana JA. Proteomic typing of amyloid deposits in systemic amyloidoses. Vol. 18, Amyloid. 2011. pp. 177\u201382.","DOI":"10.3109\/13506129.2011.630762"},{"issue":"8","key":"9546_CR13","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1182\/blood-2011-07-365510","volume":"119","author":"F Brambilla","year":"2012","unstructured":"Brambilla F, Lavatelli F, Di Silvestre D, Valentini V, Rossi R, Palladini G, et al. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. Blood. 2012;119(8):1844\u20137.","journal-title":"Blood"},{"issue":"7","key":"9546_CR14","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3324\/haematol.2013.102764","volume":"99","author":"JA Vrana","year":"2014","unstructured":"Vrana JA, Theis JD, Dasari S, Mereuta OM, Dispenzieri A, Zeldenrust SR, et al. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics. Haematologica. 2014;99(7):1239\u201347.","journal-title":"Haematologica"},{"key":"9546_CR15","doi-asserted-by":"crossref","unstructured":"Dasari S, Theis JD, Vrana JA, Rech KL, Dao LN, Howard MT et al. Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples. Mayo Clin Proc. 2020;95(9):1852\u201364.","DOI":"10.1016\/j.mayocp.2020.06.029"},{"issue":"12","key":"9546_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/heartjnl-2023-323502","volume":"110","author":"R Cheng","year":"2024","unstructured":"Cheng R, Kittleson MM, Wechalekar AD, Alvarez-Cardona J, Mitchell JD, Scarlatelli Macedo AV, et al. Moving towards Establishing centres of excellence in cardiac amyloidosis: an international Cardio-Oncology society statement. Heart. 2024;110(12):823\u201330.","journal-title":"Heart"},{"issue":"4","key":"9546_CR17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaccao.2021.06.001","volume":"3","author":"RS Szor","year":"2021","unstructured":"Szor RS, Alencar A, Bueno BVK, Cafezeiro CRF, Alves LB, de Hajjar O. Amyloid cardiomyopathy: Establishing a patient referral center in Brazil. JACC CardioOncol. 2021;3(4):606\u201310.","journal-title":"JACC CardioOncol"},{"issue":"3","key":"9546_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/MNH.0b013e3280bdc0db","volume":"16","author":"MM Picken","year":"2007","unstructured":"Picken MM. New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens. 2007;16(3):196\u2013203.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"23","key":"9546_CR19","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1056\/NEJMoa013354","volume":"346","author":"HJ Lachmann","year":"2002","unstructured":"Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, et al. Misdiagnosis of hereditary amyloidosis as AL (Primary) amyloidosis. N Engl J Med. 2002;346(23):1786\u201391.","journal-title":"N Engl J Med"},{"issue":"3","key":"9546_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.acthis.2006.03.010","volume":"108","author":"RP Linke","year":"2006","unstructured":"Linke RP, Oos R, Wiegel NM, Nathrath WBJ. Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it. Acta Histochem. 2006;108(3):197\u2013208.","journal-title":"Acta Histochem"},{"key":"9546_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.proghi.2012.03.001","volume":"47","author":"Linke RP","year":"2012","unstructured":"Linke RP. On typing amyloidosis using immunohistochemistry. Detailled illustrations, review and a note on mass spectrometry. Prog Histochem Cytochem. 2012;47:61\u2013132.","journal-title":"Prog Histochem Cytochem"},{"key":"9546_CR22","unstructured":"Gilbertson JA, Theis JD, Vrana JA, Lachmann H, Wechalekar A, Whelan C et al. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue. Available from: http:\/\/jcp.bmj.com\/"},{"issue":"7","key":"9546_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/14789450.2017.1322905","volume":"14","author":"MM Hill","year":"2017","unstructured":"Hill MM, Mollee PN. Mass spectrometry analysis for amyloidosis typing - is the future bright for its clinical implementation? Expert Rev Proteom. 2017;14(7):565\u20136.","journal-title":"Expert Rev Proteom"},{"issue":"2","key":"9546_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1182\/blood-2011-06-358507","volume":"119","author":"SO Sch\u00f6nland","year":"2012","unstructured":"Sch\u00f6nland SO, Hegenbart U, Bochtler T, Mangatter A, Hansberg M, Ho AD, et al. Immunohistochemistry in the classification of systemic forms of amyloidosis: A systematic investigation of 117 patients. Blood. 2012;119(2):488\u201393.","journal-title":"Blood"},{"key":"9546_CR25","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez C, De Fern\u00e1ndez F, Verga L, Morbini P, Klersy C, Lavatelli F et al. A practical approach to the diagnosis of systemic amyloidoses. 2015; Available from: http:\/\/ashpublications.org\/blood\/article-pdf\/125\/14\/2239\/1383989\/2239.pdf","DOI":"10.1182\/blood-2014-11-609883"},{"issue":"16","key":"9546_CR26","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMc1917321","volume":"382","author":"S Ravichandran","year":"2020","unstructured":"Ravichandran S, Lachmann HJ, Wechalekar AD. Epidemiologic and survival trends in amyloidosis, 1987\u20132019. N Engl J Med. 2020;382(16):1567\u20138.","journal-title":"N Engl J Med"},{"key":"9546_CR27","unstructured":"Palladini G, Merlini G, How I, Treat Series. PLASMA CELL DYSCRASIAS How I treat AL amyloidosis."},{"issue":"3","key":"9546_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/ejh.13458","volume":"105","author":"OC Cohen","year":"2020","unstructured":"Cohen OC, Sharpley F, Gilbertson JA, Wechalekar AD, Sachchithanantham S, Mahmood S, et al. The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosis. Eur J Haematol. 2020;105(3):352\u20136.","journal-title":"Eur J Haematol"},{"issue":"3","key":"9546_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/cjp2.126","volume":"5","author":"T Rezk","year":"2019","unstructured":"Rezk T, Gilbertson JA, Mangione PP, Rowczenio D, Rendell NB, Canetti D, et al. The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis. J Pathol Clin Res. 2019;5(3):145\u201353.","journal-title":"J Pathol Clin Res"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-025-09546-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-025-09546-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-025-09546-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:11:34Z","timestamp":1759914694000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-025-09546-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9546"],"URL":"https:\/\/doi.org\/10.1186\/s12014-025-09546-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6124234\/v1","asserted-by":"object"}]},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Helsinki Declaration and was approved by the Ethics Committee of the Hospital das Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo, and Grupo Fleury. Written informed consent for using pathology data was obtained from all living patients. For deceased patients, no consent was required from their families.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for using pathology data was obtained from all living patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}